Lv61
2440 积分 2022-02-16 加入
Reduction of renal uptake of radiolabeled octreotate by amifostine coadministration
49分钟前
待确认
Health-related quality of life, pain, and symptomatic skeletal events with [(177)Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
1小时前
待确认
(177)Lu-PSMA-617 for metastatic prostate cancer: aiming for the right spot
4天前
已完结
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
11天前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAF (V600E) mutation-positive metastatic non-small cell lung cancer
2个月前
已完结
A phase II study of encorafenib + binimetinib combination in Chinese patients with BRAF V600E mutated metastatic non-small cell lung cancer
2个月前
已完结
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer
2个月前
已完结
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
